Cancer stem cells in bladder cancer: A revisited and evolving concept

Current Opinion in Urology

Volumn 20, Issue 5, 2010, Pages 393-397

  Chan, Keith Syson ^a   Volkmer, Jens Peter ^b,c   Weissman, Irving ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

basal cells; bladder cancer; cancer stem cells; CD47; therapeutic targeting

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKERATIN;

BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER STEM CELL; CANCER TISSUE; CELL ISOLATION; CELL SUBPOPULATION; CLINICAL TRIAL; GENE EXPRESSION PROFILING; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVIEW; STEM CELL; TUMOR CELL; XENOGRAFT;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77955473891     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32833cc9df     Document Type: Review

References (27)

1. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3:730-737.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100:3983-3988.
3. Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008; 100:672-679.
4. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-760.
5. Mackillop WJ, Bizarri JP, Ward GK. Cellular heterogeneity in normal and neoplastic human urothelium. Cancer Res 1985; 45:4360-4365.
6. Lipponen PK, Eskelinen MJ, Nordling S. Intratumoral heterogeneity of DNA indexes in transitional cell bladder cancer: Relation to tumor histology. Eur Urol 1991; 20:311-314.
7. Buick RN, Stanisic TH, Fry SE, et al. Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder. Cancer Res 1979; 39:5051-5056.
8. Kovnat A, Buick RN, Connolly JG, et al. Comparison of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics. Cancer Res 1984; 44:2530-2533.
9. Anderson KC, Simpson WG, Ballou RJ, et al. In vitro chemosensitivity of J-82 human bladder cancer cells. Urol Res 1986; 14:141-144.
10. Ward GK, Stewart SS, Price GB, Mackillop WJ. Cellular heterogeneity in normal human urothelium: An analysis of optical properties and lectin binding. J Histochem Cytochem 1986; 34:841-846.
11. Ward GK, Stewart SS, Price GB, Mackillop WJ. Cellular heterogeneity in normal human urothelium: Quantitative studies of lectin binding. Histochem J 1987; 19:337-344.
12. MDotsikas G, Konowalchuk T, Major PP, et al. Cellular heterogeneity in normal and neoplastic human urothelium: A study using murine monoclonal antibodies. Br J Cancer 1987; 56:439-444.
13. Chan KS, Espinosa I, Chao M, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A 2009; 106:14016-14021. A comprehensive study using patient bladder cancer specimens and archived tissue for the prospective isolation and molecular characterization of bladder CSCs
14. Yang YM, Chang JW. Bladder cancer initiating cells (BCICs) are among EMACD44v6+ subset: Novel methods for isolating undetermined cancer stem (initiating) cells. Cancer Invest 2008; 26:725-733.
15. She JJ, Zhang PG, Wang ZM, et al. Identification of side population cells from bladder cancer cells by DyeCycle Violet staining. Cancer Biol Ther 2008; 7:1663-1668.
16. Ning ZF, Huang YJ, Lin TX, et al. Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24. J Int Med Res 2009; 37:621-630.
17. He X, Marchionni L, Hansel DE, et al. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells 2009; 27:1487-1495.
18. Su Y, Qiu Q, Zhang X, et al. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 2010; 19:327-337.
19. Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A 2000; 97:7521-7526.
20. Kurzrock EA, Lieu DK, Degraffenried LA, et al. Label-retaining cells of the bladder: Candidate urothelial stem cells. Am J Physiol Renal Physiol 2008; 294:F1415-F1421.
21. Thangappan R, Kurzrock EA. Three clonal types of urothelium with different capacities for replication. Cell Prolif 2009; 42: 770-779. A study revealing the possible existence of normal progenitor cells in bladder urothelium.
22. Zhang Y, McNeill E, Tian H, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol 2008; 180:2226-2233.
23. Anumanthan G, Makari JH, Honea L, et al. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol 2008; 180:1778-1783.
24. Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 2006; 22:339-373.
25. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009; 23:2563-2577.
26. Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006; 6:457-464.
27. Majeti R, Chao MP, Alizadeh AA, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009; 138:286-299.